247 CMR, § 16.00
Current through Register 1536, December 6, 2024
St. 2008, c. 528 (amending M.G.L. c. 94C, §§ 7 and 9 and M.G.L. c. 112, §§ 24B1/2 and 24B3/4) authorized pharmacists and physicians to engage in collaborative drug therapy management (CDTM) in the Commonwealth pursuant to collaborative practice agreements meeting the requirements of regulations adopted by the Boards of Registration in Pharmacy and Medicine. The Board of Registration in Pharmacy has promulgated 247 CMR 16.00 in accordance with M.G.L. c. 112, §§ 24B1/2 and 24B3/4. Board of Registration in Medicine regulations (243 CMR 2.12) include additional definitions and requirements applicable to pharmacists and physicians entering into collaborative practice agreements to practice CDTM in the Commonwealth.
247 CMR, § 16.00